Filing Details
- Accession Number:
- 0001179110-16-020017
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-24 11:47:54
- Reporting Period:
- 2016-02-22
- Filing Date:
- 2016-02-24
- Accepted Time:
- 2016-02-24 11:47:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1235010 | Momenta Pharmaceuticals Inc | MNTA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1229450 | A Craig Wheeler | C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142 | President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-02-22 | 1,688 | $9.95 | 244,342 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 183,596 | Indirect | Craig Wheeler Revocable Trust |
Common Stock | 150,000 | Indirect | Craig A. Wheeler 2014 Irrevocable Trust |
Footnotes
- This sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013.
- This transaction was executed in multiple trades at prices ranging from $9.65 to $10.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.